Kurome Therapeutics is Drug Delivery in United States that focus on mediated signaling pathways business. Founded in 2019. They cover business area such as developer, novel therapy, cancer cell, pathway, exposure, chemo- and target therapy, patient, destruction, traditional therapeutic agent, adaptive resistance mechanism.
2019
( 5 years old in 2024 )
Mediated Signaling Pathways
-
3536 Edwards Road
Upper Suite 100
Cincinnati, OH 45208
United States
Private
developernovel therapycancer cellpathwayexposurechemo- and target therapypatientdestructiontraditional therapeutic agentadaptive resistance mechanism
* We use standard office opening hours in near Kurome Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kurome Therapeutics is Drug Delivery business from United States that founded in 2019 (5 years old in 2024), Kurome Therapeutics business is focusing on Mediated Signaling Pathways.
Kurome Therapeutics headquarter office and corporate office address is located in 3536 Edwards Road Upper Suite 100 Cincinnati, OH 45208 United States.
Kurome Therapeutics was founded in United States.
In 2024, Kurome Therapeutics is currently focus on mediated signaling pathways sector.
Above is snippet of Google Trends for "mediated signaling pathways" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kurome Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
